BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 34204509)

  • 1. Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases.
    Bailly C; Thuru X; Quesnel B
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.
    Niu M; Liu Y; Yi M; Jiao D; Wu K
    Front Immunol; 2022; 13():827921. PubMed ID: 35386715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sPD-1 and sPD-Ls in the pathogenesis of connective tissue disease.
    He H; He X; Zhou M; Tang Y; Dai L; Xie Z; Wang Y; Xie C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):444-454. PubMed ID: 37164928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
    Zhou J; Mahoney KM; Giobbie-Hurder A; Zhao F; Lee S; Liao X; Rodig S; Li J; Wu X; Butterfield LH; Piesche M; Manos MP; Eastman LM; Dranoff G; Freeman GJ; Hodi FS
    Cancer Immunol Res; 2017 Jun; 5(6):480-492. PubMed ID: 28522460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer.
    He Y; Zhang X; Zhu M; He W; Hua H; Ye F; Zhou X; Chen N; Li Y; Zhong W; Wu G; Cai H; Jiang W
    J Transl Med; 2023 Jan; 21(1):25. PubMed ID: 36639643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK/T-cell lymphoma, nasal-type.
    Li JW; Wei P; Guo Y; Shi D; Yu BH; Su YF; Li XQ; Zhou XY
    Am J Cancer Res; 2020; 10(12):4498-4512. PubMed ID: 33415014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy.
    Shin K; Kim J; Park SJ; Lee MA; Park JM; Choi MG; Kang D; Song KY; Lee HH; Seo HS; Lee SH; Kim B; Kim O; Park J; Kang N; Kim IH
    Sci Rep; 2023 Apr; 13(1):6952. PubMed ID: 37117200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage.
    Li Q; Chen C; Wu J; Poon LC; Wang CC; Li TC; Zhang T; Guo X; Song L; Wang X; Zhang Q; Ye Z; Yang Y; Lu J; Yao J; Ye D; Wang Y
    Hum Reprod; 2023 Nov; 38(11):2128-2136. PubMed ID: 37671597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood.
    Keber CU; Derigs M; Schultz C; Wegner M; Lingelbach S; Wischmann V; Hofmann R; Denkert C; Hegele A; Hänze J
    Cancer Immunol Immunother; 2022 Oct; 71(10):2381-2389. PubMed ID: 35184226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
    Scirocchi F; Strigari L; Di Filippo A; Napoletano C; Pace A; Rahimi H; Botticelli A; Rughetti A; Nuti M; Zizzari IG
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1
    Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F
    Front Immunol; 2022; 13():830606. PubMed ID: 35935985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
    Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
    Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells.
    Pen JJ; Keersmaecker BD; Heirman C; Corthals J; Liechtenstein T; Escors D; Thielemans K; Breckpot K
    Gene Ther; 2014 Mar; 21(3):262-71. PubMed ID: 24401835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of soluble co-stimulatory molecule PD-L1 (B7-H1) in the plasma of viraemic HIV-1
    León-Flores A; Del Río Estrada PM; Álvarez-García LX; Piten-Isidro E; Reyes-Terán G
    Immunol Lett; 2018 Nov; 203():70-79. PubMed ID: 30236481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
    Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.
    Kruger S; Legenstein ML; Rösgen V; Haas M; Modest DP; Westphalen CB; Ormanns S; Kirchner T; Heinemann V; Holdenrieder S; Boeck S
    Oncoimmunology; 2017; 6(5):e1310358. PubMed ID: 28638732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis.
    Li Y; Xiao Y; Su M; Zhang R; Ding J; Hao X; Ma Y
    Exp Ther Med; 2016 Jan; 11(1):251-256. PubMed ID: 26889250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy.
    Khan M; Zhao Z; Arooj S; Fu Y; Liao G
    Front Immunol; 2020; 11():587460. PubMed ID: 33329567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
    Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
    Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-dependent PD-L1/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF.
    Baggio C; Ramaschi GE; Oliviero F; Ramonda R; Sfriso P; Trevisi L; Cignarella A; Bolego C
    Biomed Pharmacother; 2023 Jun; 162():114670. PubMed ID: 37068331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.